Prevalence and associated factors of orphan symptoms in advanced cancer patients: a multicenter observational study

[1] Seow H(2011)Trajectory of performance status and symptom scores for patients with cancer during the last six months of life J Clin Oncol 29 1151-1158

[2] Barbera L(2019)Quality of life and symptom intensity over time in people with cancer receiving palliative care: results from the international European Palliative Care Cancer Symptom study PLoS One 14 e0222988-643

[3] Sutradhar R(2017)The Edmonton Symptom Assessment System 25 Years Later: past, present, and future developments J Pain Symptom Manag 53 630-1057

[4] Howell D(2019)A brief, patient- and proxy-reported outcome measure in advanced illness: validity, reliability and responsiveness of the Integrated Palliative care Outcome Scale (IPOS) Palliat Med 33 1045-405

[5] Dudgeon D(2013)Grande G; National Association for Hospice at Home, The Carer Support Needs Assessment Tool (CSNAT) for use in palliative and end-of-life care at home: a validation study J Pain Symptom Manag 46 395-3528

[6] Atzema C(2013)Orphan symptoms in advanced cancer patients followed at home Support Care Cancer 21 3525-1735

[7] Liu Y(2019)Which symptoms and problems do advanced cancer patients admitted to specialized palliative care report in addition to those included in the EORTC QLQ-C15-PAL? A register-based national study Support Care Cancer 28 1725-74

[8] Husain A(2019)Systematic bias in cancer patient-reported outcomes: symptom ‘orphans’ and ‘champions’ BMJ Support Palliat Care 9 67-104

[9] Sussman J(2007)Symptom prevalence in patients with incurable cancer: a systematic review J Pain Symptom Manag 34 94-1704

[10] Earle C(2018)Frequency, outcomes, and associated factors for opioid-induced neurotoxicity in patients with advanced cancer receiving opioids in inpatient palliative care J Palliat Med 21 1698-346

[1] Seow H(2011)Trajectory of performance status and symptom scores for patients with cancer during the last six months of life J Clin Oncol 29 1151-1158

[2] Barbera L(2019)Quality of life and symptom intensity over time in people with cancer receiving palliative care: results from the international European Palliative Care Cancer Symptom study PLoS One 14 e0222988-643

[3] Sutradhar R(2017)The Edmonton Symptom Assessment System 25 Years Later: past, present, and future developments J Pain Symptom Manag 53 630-1057

[4] Howell D(2019)A brief, patient- and proxy-reported outcome measure in advanced illness: validity, reliability and responsiveness of the Integrated Palliative care Outcome Scale (IPOS) Palliat Med 33 1045-405

[5] Dudgeon D(2013)Grande G; National Association for Hospice at Home, The Carer Support Needs Assessment Tool (CSNAT) for use in palliative and end-of-life care at home: a validation study J Pain Symptom Manag 46 395-3528

[6] Atzema C(2013)Orphan symptoms in advanced cancer patients followed at home Support Care Cancer 21 3525-1735

[7] Liu Y(2019)Which symptoms and problems do advanced cancer patients admitted to specialized palliative care report in addition to those included in the EORTC QLQ-C15-PAL? A register-based national study Support Care Cancer 28 1725-74

[8] Husain A(2019)Systematic bias in cancer patient-reported outcomes: symptom ‘orphans’ and ‘champions’ BMJ Support Palliat Care 9 67-104

[9] Sussman J(2007)Symptom prevalence in patients with incurable cancer: a systematic review J Pain Symptom Manag 34 94-1704

[10] Earle C(2018)Frequency, outcomes, and associated factors for opioid-induced neurotoxicity in patients with advanced cancer receiving opioids in inpatient palliative care J Palliat Med 21 1698-346